• Polygodial: Designing Better TRPA1 Assays

  2026-09-23

  Polygodial is a research-grade TRPA1 channel activator for examining calcium-dependent sensory signaling. This article presents an evidence-driven assay framework that separates channel engagement from NFAT, TSLP, and inflammatory readouts.

• AZD8055: Practical mTOR Inhibitor Workflow

  2026-09-22

  AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolic responses. It is suited to preclinical mechanistic workflows, but its DMSO-only solubility and limited clinical benefit make it unsuitable for water-based formulations or clinical efficacy prediction.

• Fludarabine Workflows for Oncology Research

  2026-09-22

  Build reproducible Fludarabine experiments around DNA synthesis inhibition, cell-cycle analysis, and apoptosis readouts in leukemia and multiple myeloma models. A paired immune-assay strategy also helps distinguish direct cytotoxicity from exploratory effects on tumor antigen presentation.

• 3X FLAG Peptide for Mechanistic Cancer Assays

  2026-09-21

  The 3X (DYKDDDDK) Peptide can do more than improve FLAG detection: it can help build a controlled assay architecture for testing the MAZ–BCKDK–G6PD metabolic axis in triple-negative breast cancer. This guide connects epitope-tag chemistry, interaction validation, purification, and metal-aware assay design.

• FLAG tag Strategy for VPS13C Mechanistic Studies

  2026-09-21

  A translational framework for using the FLAG tag Peptide (DYKDDDDK) to improve VPS13C purification, detection, and conformational-state analysis while preserving experimental discipline around calmodulin, calcium signaling, and lipid-transfer regulation.

• Human Organellar SPFH Complexes: Cryo-EM Architectures

  2026-09-20

  This study defines the architectures of two previously unresolved human organellar SPFH assemblies using single-particle cryo-EM. It shows that Erlin1/2 and PHB1/2 form distinct heterodimeric cages with different stoichiometries, while preserving broader principles of SPFH ring organization and conformational flexibility.

• Mtb Reprograms ATP6V1E1 Phosphorylation via BMX

  2026-09-19

  A 2026 Nature Communications study identifies the Mtb secreted acyltransferase Chp2/Rv1184 as a regulator of host lysosomal acidification. By promoting BMX-dependent phosphorylation of ATP6V1E1, Chp2 disrupts V-ATPase assembly, weakens phagosomal acidification, and supports bacterial persistence in macrophages and mice.

• 3X (DYKDDDDK) Peptide: FANCJ Workflow Guide

  2026-09-18

  The 3X (DYKDDDDK) Peptide supports sensitive capture, elution, and verification of recombinant proteins, with particular value in demanding FANCJ helicase and structural-biology workflows. This guide connects FLAG-tagged protein handling with metal-aware immunodetection, assay controls, and practical troubleshooting.

• Camostat Mesilate for Reliable Cell Assays

  2026-09-18

  Camostat Mesilate (SKU B2082) offers a defined, soluble trypsin-like protease inhibitor for interpreting viability, proliferation, cytotoxicity, ENaC, plasmin, and TGF-β experiments. This scenario-based guide explains formulation, dose selection, controls, pathway-specific interpretation, and practical vendor evaluation.

• 7ACC2: Mapping Lactate Flux in Tumor Models

  2026-09-17

  7ACC2 is a potent monocarboxylate transporter 1 inhibitor for resolving lactate and pyruvate transport in cancer metabolism research. This assay-centered guide explains how to distinguish direct transport effects from broader immunometabolic consequences and radiosensitization.

• PFHxS Hepatotoxicity and PPAR Signaling in Zebrafish

  2026-09-17

  A 2024 Environmental Science & Technology study shows that environmentally relevant perfluorohexanesulfonic acid exposure can disrupt liver development and function in larval zebrafish through PPAR-associated mechanisms. By combining transcriptomics, tissue pathology, biochemical measurements, targeted gene analysis, pharmacological antagonism, and morpholino knockdown, the study moves beyond hazard description toward mechanistic interpretation.

• Smg5–Hnrnpl Control of Oligodendrocyte Myelination

  2026-09-16

  This study identifies an Smg5-dependent nonsense-mediated mRNA decay pathway that supports oligodendrocyte differentiation by controlling aberrant Hnrnpl transcripts. Its mechanistic model links RNA surveillance to HNRNPL-dependent alternative splicing of Mag and Nfasc, providing a molecular explanation for defective myelination and motor impairment after Smg5 loss.

• A-769662: Designing Better AMPK Assays

  2026-09-16

  A-769662 is a reversible AMPK activator that can separate direct kinase signaling from downstream metabolic and autophagy phenotypes. This guide translates recent AMPK–ULK1 findings into a practical framework for energy metabolism regulation, fatty acid synthesis inhibition, and proteasome studies.

• FLAG tag Peptide: Workflow & Troubleshooting

  2026-09-15

  Use the FLAG tag Peptide (DYKDDDDK) to combine selective recombinant protein detection with gentle affinity purification. This guide translates the product’s elution chemistry and a recent kinesin-adaptor study into practical construct, capture, assay, and troubleshooting decisions.

• LTI6426 Enhances Panobinostat in Multiple Myeloma

  2026-09-15

  The reference study shows that the protein disulfide isomerase inhibitor LTI6426 markedly enhances low-dose panobinostat activity in multiple myeloma models, including a proteasome inhibitor-resistant mouse model. Its mechanistic contribution is the identification of a shared endoplasmic reticulum stress transcriptional response involving ATF3, DDIT3/CHOP, and DNAJB1, which may support pharmacodynamic monitoring in future studies.

7861 records 1/525 page Next 12345 下5页 Last page